AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SURGICAL INNOVATIONS GROUP PLC

Regulatory Filings Dec 3, 2018

7938_rns_2018-12-03_94f2d4c6-0018-4963-b27f-79f8122be423.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0932J

Surgical Innovations Group PLC

03 December 2018

Surgical Innovations Group plc

("Surgical Innovations" or "the "Company")

Appointment of Nominated Adviser and Broker

Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces the appointment of Nplus1 Singer Advisory LLP ("N+1 Singer") as Nominated Adviser and sole Broker to the Company with immediate effect.

For further information contact:

Surgical Innovations Group Plc www.sigroupplc.com
Nigel Rogers, Executive Chairman Tel: +44 (0)113 230 7597
Melanie Ross, COO and CFO
Walbrook PR (Financial PR & Investor Relations) Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus Mob: +44 (0)7980 541 893
Lianne Cawthorne Mob: +44 (0)7584 391 303
N+1 Singer - Nominated Adviser and Broker +44 (0)20 7496 3000
Richard Lindley
Rachel Hayes

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

APPFDIFDSFASESF

Talk to a Data Expert

Have a question? We'll get back to you promptly.